Blood markers for poor outcomes after sepsis in cancer surgery
Treatments studied
Part of Infections clinical trials.
This study looks at blood markers (epigenetics) to better understand why some people have a harder time recovering from a severe infection after major cancer surgery. The goal is to find early signs of poor outcomes in men aged 45–75 with post-surgery sepsis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male
- You are between 45 and 75 years old
- You are having or have had major surgery for cancer of the esophagus or digestive system
- You have a serious infection after surgery (gram-negative bacteria), either confirmed or suspected
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if certain blood markers (CRP, CRP/albumin ratio, and neutrophil/lymphocyte ratio) can predict how well sepsis patients with normal blood pressure will do. It aims to help doctors better manage infections and survival.
This trial looks at how certain genetic elements may affect the immune system in older adults with sepsis. It aims to understand why older patients may respond differently to severe infections.
This study is looking at how sepsis affects bone marrow to understand why some people get very sick. If you are in the ICU with a serious infection or another critical illness, you may be eligible to join.
This study uses special blood testing to learn what is happening in the immune system during sepsis in children and how it may relate to organ injury. Your results may help doctors recognize and treat sepsis earlier and more accurately.
This study looks at how the immune system reacts to sepsis (a severe infection that causes organs to fail) and whether there are lasting effects on health. It may help researchers understand why some people recover well and others don’t.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
Hear when a new Sepsis Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.